accountbusiness and earnings outlook for the oil drillers. The stock has suffered a 36% drop in 2010. 6. King Pharmaceuticals King Pharmaceuticals(KG), developer and marketer of branded prescription products related to neuroscience, has disappointed on many...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Dogs of the S&P 500: Mid-Year Losers
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account